Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Examining the factor structure of the multiple sclerosis impact scale.
Similarities between Inherited Demyelinating Neuropathies and Wallerian Degeneration: An Old Repair Program May Cause Myelin and Axon Perturbation under Nonlesion Conditions.
Everyday memory impairment, neuroradiological findings and physical disability in multiple sclerosis.
Cognitive functions in multiple sclerosis: impact of gray matter integrity.
Patients with neuromuscular disorder.
Intrathecal, polyspecific antiviral immune response in oligoclonal band negative multiple sclerosis.
Genomic Characterization of Japanese Macaque Rhadinovirus: A Novel Herpesvirus Isolated from a Nonhuman Primate with a Spontaneous Inflammatory Demyelinating Disease.
Natalizumab and multiple sclerosis.
Pharmacology of the sphingosine-1-phosphate signalling system.
Multiple sclerosis and pregnancy.
Myelin damage and repair in pathologic CNS: challenges and prospects.
Association between a Functional HLA-G 14-bp Insertion/deletion Polymorphism and Susceptibility to Autoimmune Diseases: A Meta-analysis.
Stress, Multiple Sclerosis, and Everyday FunctioningA Review of the Literature with Implications for Intervention.
Merck Loses Protection for Patent on Zocor
Mesenchymal stem cells differentially modulate effector CD8+ T cell subsets and exacerbate experimental autoimmune encephalomyelitis.
Impact of a 10-week individualized exercise program on physical function and fatigue of people with multiple sclerosis: a pilot study.
The influence of age and illness duration on cognitive impairment in aging patients with relapsing-remitting multiple sclerosis (RR-MS).
Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison. Curr Med
Normatization of the symbol digit modalities test-oral version in a latin american country.
Role of interferon-beta in Mycobacterium avium subspecies paratuberculosis antibody response in Sardinian MS patients.
[Pegylated interferon beta 1a : A new therapy option for treatment of relapsing-remitting multiple sclerosis].
Synaptic vesicle release regulates myelin sheath number of individual oligodendrocytes in vivo.
Label-free method for anti-glucopeptide antibody detection in Multiple Sclerosis.
Fully automated open-source lesion mapping of T2-FLAIR images with FSL correlates with clinical disability in MS.
Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trial-study protocol.
Pages
« first
‹ previous
…
462
463
464
465
466
467
468
469
470
…
next ›
last »